A detailed history of Wells Fargo & Company transactions in Biolife Solutions Inc stock. As of the latest transaction made, Wells Fargo & Company holds 104,285 shares of BLFS stock, worth $2.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
104,285
Previous 68,461 52.33%
Holding current value
$2.67 Million
Previous $1.27 Million 76.04%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$15.14 - $22.99 $542,375 - $823,593
35,824 Added 52.33%
104,285 $2.23 Million
Q1 2024

May 10, 2024

BUY
$15.35 - $18.82 $909,978 - $1.12 Million
59,282 Added 645.84%
68,461 $1.27 Million
Q4 2023

Feb 09, 2024

BUY
$8.99 - $16.86 $18,672 - $35,018
2,077 Added 29.25%
9,179 $149,000
Q3 2023

Nov 13, 2023

SELL
$10.81 - $22.96 $100,878 - $214,262
-9,332 Reduced 56.78%
7,102 $98,000
Q2 2023

Aug 15, 2023

BUY
$17.19 - $24.34 $145,066 - $205,405
8,439 Added 105.55%
16,434 $363,000
Q1 2023

May 12, 2023

BUY
$17.67 - $26.07 $121,887 - $179,830
6,898 Added 628.81%
7,995 $173,000
Q4 2022

Feb 13, 2023

SELL
$16.95 - $25.07 $19,763 - $29,231
-1,166 Reduced 51.52%
1,097 $19,000
Q3 2022

Nov 14, 2022

SELL
$14.64 - $26.7 $28,138 - $51,317
-1,922 Reduced 45.93%
2,263 $52,000
Q2 2022

Aug 12, 2022

SELL
$10.54 - $24.2 $44,689 - $102,608
-4,240 Reduced 50.33%
4,185 $57,000
Q1 2022

May 16, 2022

SELL
$20.81 - $37.29 $113,685 - $203,715
-5,463 Reduced 39.34%
8,425 $192,000
Q4 2021

Feb 14, 2022

SELL
$32.99 - $58.55 $101,939 - $180,919
-3,090 Reduced 18.2%
13,888 $517,000
Q3 2021

Nov 15, 2021

SELL
$42.03 - $60.5 $12,777 - $18,392
-304 Reduced 1.76%
16,978 $719,000
Q2 2021

Aug 16, 2021

SELL
$29.51 - $44.62 $6,167 - $9,325
-209 Reduced 1.19%
17,282 $768,000
Q1 2021

May 13, 2021

SELL
$32.95 - $44.24 $915,449 - $1.23 Million
-27,783 Reduced 61.37%
17,491 $629,000
Q4 2020

Feb 09, 2021

SELL
$27.5 - $45.75 $892,265 - $1.48 Million
-32,446 Reduced 41.75%
45,274 $1.81 Million
Q3 2020

Nov 05, 2020

BUY
$16.04 - $28.94 $136,067 - $245,498
8,483 Added 12.25%
77,720 $2.25 Million
Q2 2020

Aug 13, 2020

BUY
$9.2 - $17.06 $1,738 - $3,224
189 Added 0.27%
69,237 $1.13 Million
Q1 2020

May 14, 2020

BUY
$8.36 - $17.03 $577,241 - $1.18 Million
69,048 New
69,048 $656,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.09B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.